Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date
Authors
Keywords
-
Journal
Therapeutics and Clinical Risk Management
Volume Volume 16, Issue -, Pages 681-688
Publisher
Informa UK Limited
Online
2020-07-29
DOI
10.2147/tcrm.s224772
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
- (2019) Emelia J. Benjamin et al. CIRCULATION
- Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study
- (2019) Rolf Wachter et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction
- (2019) Akshay S. Desai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF
- (2019) John J. V. McMurray et al. CIRCULATION
- Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed ( de novo ) heart failure: a subgroup analysis of the TRANSITION study
- (2019) Michele Senni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Predicting adults likely to develop heart failure using readily available clinical information
- (2019) Tova M. Bergsten et al. PREVENTIVE MEDICINE
- Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)
- (2018) James L. Januzzi et al. AMERICAN HEART JOURNAL
- Effects of Sacubitril/Valsartan Versus Irbesartan in Patients with Chronic Kidney Disease: A Randomised Double-Blind Trial
- (2018) Richard Haynes et al. CIRCULATION
- The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions
- (2018) Andrew P. Ambrosy et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cognition- and Dementia-Related Adverse Effects With Sacubitril-Valsartan: Analysis of the FDA Adverse Event Report System Database
- (2018) Amichai Perlman et al. JOURNAL OF CARDIAC FAILURE
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- EFFECT OF SACUBITRIL/VALSARTAN COMPARED WITH ENALAPRIL, ACCORDING TO ETIOLOGY IN PARADIGM-HF
- (2017) Joanne Simpson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
- (2017) Jelena P Seferovic et al. Lancet Diabetes & Endocrinology
- Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition
- (2016) Scott A. Hubers et al. CIRCULATION
- Geographic variations in the PARADIGM-HF heart failure trial
- (2016) Søren Lund Kristensen et al. EUROPEAN HEART JOURNAL
- Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens
- (2016) Michele Senni et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2016) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies
- (2016) Kwadwo Osei Bonsu et al. Therapeutics and Clinical Risk Management
- Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
- (2015) Akshay S. Desai et al. EUROPEAN HEART JOURNAL
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction
- (2015) Horng H. Chen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Time and Technology Will Tell
- (2014) Brent N. Reed et al. Heart Failure Clinics
- Adrenergic Nervous System in Heart Failure
- (2013) Anastasios Lymperopoulos et al. CIRCULATION RESEARCH
- Lifetime Risk for Heart Failure Among White and Black Americans
- (2013) Mark D. Huffman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction
- (2012) Benjamin A. Steinberg et al. CIRCULATION
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
- (2011) C.M. O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Valsartan
- (2010) Henry R. Black et al. DRUGS
- Differences in the Incidence of Congestive Heart Failure by Ethnicity
- (2008) Hossein Bahrami et al. ARCHIVES OF INTERNAL MEDICINE
- Safety and Efficacy of Outpatient Nesiritide in Patients With Advanced Heart Failure
- (2008) Clyde W. Yancy et al. Circulation-Heart Failure
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started